Zsofia Kiss

Dr. Zsofia Kiss


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
ZKZsofia Kiss
Zsofia Kiss
VMVicente Medina
Vicente Medina
BFBryce Falk
Bryce Falk
Criniviruses comprise one of the genera within the family Closteroviridae. Members in this family are restricted to the phloem and rely on whitefly vectors of the genera Bemisia and/or Trialeurodes for plant-to-plant transmission. All criniviruses have bipartite, positive-sense single-stranded RNA genomes, although there is an unconfirmed report of one having a tripartite genome. Lettuce infectious yellows virus (LIYV) is the type species of the genus, the best studied so far of the criniviruses and the first for which a reverse genetics system was developed. LIYV RNA 1 encodes for proteins predicted to be involved in replication, and alone is competent for replication in protoplasts. Replication results in accumulation of cytoplasmic vesiculated membranous structures which are characteristic of most studied members of the Closteroviridae. These membranous structures, often referred to as Beet yellows virus (BYV)-type vesicles, are likely sites of RNA replication. LIYV RNA 2 is replicated in trans when co-infecting cells with RNA 1, but is temporally delayed relative to RNA 1. Efficient RNA 2 replication also is dependent on the RNA 1-encoded RNA-binding protein, P34. No LIYV RNA 2-encoded proteins have been shown to affect RNA replication, but at least four, CP (major coat protein), CPm (minor coat protein), Hsp70h, and P59 are virion structural components and CPm is a determinant of whitefly transmissibility. Roles of other LIYV RNA 2-encoded proteins are largely as yet unknown, but P26 is a non-virion protein that accumulates in cells as characteristic plasmalemma deposits which in plants are localized within phloem parenchyma and companion cells over plasmodesmata connections to sieve elements. The two remaining crinivirus-conserved RNA 2-encoded proteins are P5 and P9. P5 is 39 amino acid protein and is encoded at the 5′ end of RNA 2 as ORF 1 and is part of the hallmark closterovirus gene array. The orthologous gene in BYV has been shown to play a role in cell-to-cell movement and indicated to be localized to the endoplasmic reticulum as a Type III integral membrane protein. The other small protein, P9, is encoded by ORF 4 overlaps with ORF 3 that encodes the structural protein, P59. P9 seems to be unique to viruses in the genus Crinivirus, as no similar protein has been detected in viruses of the other two genera of the Closteroviridae.

25 December 2024 in Cancers
Verified
Journal Article
Open access
PDF file
JYJie Zeng Yu
Jie Zeng Yu
ZKZsofia Kiss
Zsofia Kiss
Weijie MaWeijie Ma
Weijie Ma
RLRuqiang Liang
Ruqiang Liang
TLTianhong Li
Tianhong Li
Patient-centered precision oncology strives to deliver individualized cancer care. In lung cancer, preclinical models and technological innovations have become critical in advancing this approach. Preclinical models enable deeper insights into tumor biology and enhance the selection of appropriate systemic therapies across chemotherapy, targeted therapies, immunotherapies, antibody–drug conjugates, and emerging investigational treatments. While traditional human lung cancer cell lines offer a basic framework for cancer research, they often lack the tumor heterogeneity and intricate tumor–stromal interactions necessary to accurately predict patient-specific clinical outcomes. Patient-derived xenografts (PDXs), however, retain the original tumor’s histopathology and genetic features, providing a more reliable model for predicting responses to systemic therapeutics, especially molecularly targeted therapies. For studying immunotherapies and antibody–drug conjugates, humanized PDX mouse models, syngeneic mouse models, and genetically engineered mouse models (GEMMs) are increasingly utilized. Despite their value, these in vivo models are costly, labor-intensive, and time-consuming. Recently, patient-derived lung cancer organoids (LCOs) have emerged as a promising in vitro tool for functional precision oncology studies. These LCOs demonstrate high success rates in growth and maintenance, accurately represent the histology and genomics of the original tumors and exhibit strong correlations with clinical treatment responses. Further supported by advancements in imaging, spatial and single-cell transcriptomics, proteomics, and artificial intelligence, these preclinical models are reshaping the landscape of drug development and functional precision lung cancer research. This integrated approach holds the potential to deliver increasingly accurate, personalized treatment strategies, ultimately enhancing patient outcomes in lung cancer.

1 November 2026 in Pathogens
Verified
Journal Article
Open access
PDF file
RSRossana Souza
Rossana Souza
WRWellington Francisco Rodrigues
Wellington Francisco Rodrigues
CMCamila Botelho Miguel
Camila Botelho Miguel
Christophe MorisseauChristophe Morisseau
Christophe Morisseau
ZKZsofia Kiss
Zsofia Kiss
MSMarcos Augusto dos Santos
Marcos Augusto dos Santos
Sepsis-related transcriptomic signatures may differ across tissues and clinical settings, complicating their reproducibility and biological interpretation. We analyzed three public human microarray datasets spanning blood and skeletal muscle (GSE12624, GSE13205, and GSE69063; 26, 21, and 30 participants, respectively) using regularized log-odds least-squares feature screening and repeated participant-level cross-validation, with feature selection restricted to training folds. Stable candidates were defined by selection in at least 80% of training partitions and characterized using exploratory within-cohort expression comparisons and separate functional annotations. Mean internally cross-validated areas under the receiver operating characteristic curve (AUCs) were 0.735 ± 0.080, 1.000 ± 0.000, and 0.974 ± 0.020, respectively. Eighteen genes met the stability criterion, six per dataset, but none did so in more than one dataset. In GSE13205, AQP4, CA14, CHI3L1, LGI1, MYH7B, and SLPI showed complete apparent univariate separation (AUC = 1.000; Benjamini–Hochberg-adjusted p = 2.78 × 10−5), although these comparisons were not independent of candidate selection. Functional characterization retrieved 211 distinct Gene Ontology terms, 41 gene–pathway associations, and five database-derived functional associations. These findings support context-dependent candidate characterization, rather than independent biomarker validation, and motivate evaluation in distinct clinical populations.